Diagnoctic test accuracy of nucleated red blood cells in non-hematologic intensive care patients (meta-analysis)
N.A. Chulakova,
No information about this author
А.Ф. Потапов,
No information about this author
K.V. Chulakov
No information about this author
et al.
Russian Journal of Anesthesiology and Reanimatology,
Journal Year:
2025,
Volume and Issue:
2, P. 68 - 68
Published: April 14, 2025
Background.
Nucleated
red
blood
cells
(NRBC)
are
reticulocyte
precursors
detected
in
the
complete
cell
count
and
absent
bloodstream
of
a
healthy
adult.
The
presence
NRBC
adult
non-hematologic
patients
is
being
studied
as
biomarker
an
unfavorable
outcome.
Objective.
To
determine
NRBC-positive
patients’
prevalence
intensive
care
unit
(ICU)
assess
diagnostic
accuracy
predictor
mortality.
Material
methods.
A
meta-analysis
that
included
19
studies
with
5785
severe
critically
ill
was
performed:
16
articles
contained
qualitative
data
5
had
quantitative
assays.
literature
search
conducted
following
databases
—
PubMed,
Researcher
Gate
e-library.
Risk
bias
non-randomized
assessed
using
Russian-language
version
Newcastle
Ottawa
Scale,
test
additionally
evaluated
QUADAS
Questionnaire.
Results.
pooled
ICU
36.6%.
overall
mortality
49.0%.
weighted
mean
difference
values
between
survivors
non-survivors
–520.43
μl–1,
for
ARDS:
–1093.11
without
–282.87
μl–1.
univariate
analysis
showed
risk
ratio
(RR)
intrahospital
all-cause
increased
4.28-fold
(95%
CI
2.63—6.94,
p<0.00001,
I2=96%,
p<0.00001)
patients,
multivariate
(Cox
Regression)
hazard
(HR)
1.26
(CI
95%
1.00—1.59,
p=0.05,
I2=65%,
p=0.04).
Hierarchical
summary
receiver
operating
characteristic
areas
under
curves
0.745,
sensitivity
specificity
were
72.6%
79.5%
respectively,
73.7%.
Conclusion.
nucleated
hematopathology
associated
hypoxia
and/or
release
cytokines,
can
be
used
predictor.
Language: Английский
Immunogenicity and Efficacy of Combined mRNA Vaccine Against Influenza and SARS-CoV-2 in Mice Animal Models
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(11), P. 1206 - 1206
Published: Oct. 24, 2024
The
combined
or
multivalent
vaccines
are
actively
used
in
pediatric
practice
and
offer
a
series
of
advantages,
including
reduced
number
injections
visits
to
the
doctor,
simplicity
vaccination
schedule
minimization
side
effects,
easier
vaccine
monitoring
storage,
lower
costs.
widespread
use
has
shown
potential
increase
coverage
against
single
infections.
mRNA
platform
been
be
effective
COVID-19
pandemic
enables
development
vaccines.
There
currently
no
mRNA-based
approved
for
humans.
Some
studies
have
that
different
components
can
interact
decrease
immunogenicity
efficacy
vaccine.
Language: Английский
Nucleated red blood cells as a prognostic marker for mortality in patients with SARS-CoV-2-induced ARDS: an observational study
Anna Kirsch,
No information about this author
Felix Niebhagen,
No information about this author
Miriam Goldammer
No information about this author
et al.
Journal of Anesthesia Analgesia and Critical Care,
Journal Year:
2024,
Volume and Issue:
4(1)
Published: June 28, 2024
Abstract
Background
The
presence
of
nucleated
red
blood
cells
(NRBCs)
in
the
peripheral
critically
ill
patients
is
associated
with
poor
outcome.
Evidence
regarding
predictive
value
NRBCs
SARS-CoV-2-induced
acute
respiratory
distress
syndrome
(ARDS)
remains
elusive.
aim
this
study
was
to
evaluate
validity
these
patients.
Methods
Daily
NRBC
values
adult
ARDS
were
assessed
and
their
for
mortality
statistically
evaluated.
A
cut-off
level
based
on
patient’s
maximum
during
ICU
stay
calculated
further
specified
according
Youden’s
method.
Based
value,
analyses
such
as
logistic
regression
models
survival
performed.
Results
413
analyzed.
Patients
who
did
not
survive
had
significantly
higher
compared
survived
(1090/µl
[310;
3883]
vs.
140/µl
[20;
500];
p
<
0.0001).
severe
(
n
=
374)
moderate
38)
(490/µl
[120;
1890]
30/µl
[10;
476];
≥
500/µl
found
best
stratify
risk
a
longer
duration
(12
[8;
18]
18
[13;
27]
days;
0.0001)
mechanical
ventilation
(10
[6;
16]
17
[12;
26]
Logistic
analysis
multivariate
adjustment
showed
be
an
independent
factor
(odds
ratio
(OR)
4.72;
95%
confidence
interval
(CI)
2.95–7.62,
below
threshold
significant
advantage
over
those
above
(median
32
[95%
CI
8.7–43.3]
21
days
18.2–23.8],
log-rank
test,
0.05).
once
reached
increased
long-term
489
days,
0.0029,
hazard
(HR)
3.2,
1.2–8.5).
Conclusions
predict
high
prognostic
power.
Further
studies
are
required
confirm
clinical
impact
eventually
enhance
decision
making.
Language: Английский
Evaluation of Nucleated Red Blood Cells in Peripheral Blood Increases the Predictive Value of Pediatric Critical Illness Score in Infants With Severe Pneumonia at 28 Days
Pediatric Pulmonology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 24, 2024
ABSTRACT
Objective
This
study
aimed
to
evaluate
the
predictive
value
of
combining
nucleated
red
blood
cells
(NRBC)
with
pediatric
critical
illness
score
(PCIS)
in
infants
severe
pneumonia
at
28
days.
Methods
retrospective
was
conducted
Pediatric
Intensive
Care
Unit
(PICU)
First
People's
Hospital
Bijie
and
included
from
September
1,
2021,
August
31,
2022.
Demographic,
clinical,
laboratory
data
were
extracted
electronic
medical
records,
differences
between
groups
compared.
Variables
showing
significant
binary
multivariable
logistic
regression
analysis
explore
independent
risk
factors
for
mortality
pneumonia.
A
receiver
operating
characteristic
(ROC)
curve
used
patient
outcomes
Results
The
128
patients;
days,
96
survived
(survivor
group),
32
had
died
(nonsurvivor
group).
Compared
survivor
group,
nonsurvivor
group
lower
levels
platelets
[348
(239–496)
versus
431
(324–540)
×10
9
/L;
p
=
0.023],
albumin
[35.7
±
5.2
vs.
37.9
4.4
g/L;
0.022],
CD3
[36.9
1.7
47.6
1.8%;
<
0.001],
CD4
[20.4
1.2
23.6
1.9%;
IgG
[4.9
1.0
6.4
0.7
IgA
[0.5
0.1
0.8
25‐hydroxyvitamin
D(25(OH)D)
[21.1
30.7
1.36
ng/mL;
PCIS
[72.8
7.8
87.5
6.2;
P
<0.001],
a
greater
NRBC
level
[0.450
(0.162–0.832)
0.185
(0.100–0.500)
0.005].
Binary
revealed
that
count
(odds
ratio
(OR)
2.46,
95%
confidence
interval
[CI]
1.427–4.239;
0.001)
(OR
0.775,
CI:
0.644–0.934;
0.008)
predictors
28‐day
survival
an
area
under
(AUC)
0.782
(95%
0.680–0.884),
AUC
0.719
0.622–0.816),
when
combined,
0.929
0.880–0.978).
Conclusion
are
prognosis
pneumonia,
their
combination
can
increase
Language: Английский